Primary |
Lung Neoplasm Malignant |
17.5% |
Product Used For Unknown Indication |
17.5% |
Pruritus |
17.5% |
Medical Diet |
15.0% |
Hodgkin's Disease |
12.5% |
Hypopharyngeal Cancer |
7.5% |
Rhinitis Allergic |
7.5% |
Breast Cancer |
2.5% |
Rash |
2.5% |
|
Postpartum Haemorrhage |
22.2% |
Caesarean Section |
11.1% |
Dyspnoea |
11.1% |
Hyponatraemia |
11.1% |
Palmar-plantar Erythrodysaesthesia Syndrome |
11.1% |
Pyrexia |
11.1% |
Respiratory Disorder |
11.1% |
Thrombocytopenia |
11.1% |
|
Secondary |
Premedication |
31.9% |
Product Used For Unknown Indication |
15.7% |
Breast Cancer |
4.6% |
Drug Use For Unknown Indication |
4.6% |
Chronic Lymphocytic Leukaemia |
4.5% |
Insomnia |
3.7% |
Prophylaxis |
3.7% |
Pruritus |
3.2% |
Lymphoma |
2.8% |
Hypertension |
2.8% |
Chemotherapy |
2.6% |
Pain |
2.6% |
Constipation |
2.5% |
Depression |
2.5% |
Asthma |
2.3% |
B-cell Lymphoma |
2.2% |
Infection |
2.1% |
Wound Complication |
2.1% |
Convulsion Prophylaxis |
1.9% |
Ill-defined Disorder |
1.9% |
|
Malaise |
12.7% |
Thrombocytopenia |
7.8% |
Vomiting |
7.2% |
Oxygen Saturation Decreased |
6.6% |
Sepsis |
5.4% |
Hypothyroidism |
4.8% |
Neuropathy Peripheral |
4.8% |
Pruritus |
4.8% |
Dyspnoea |
4.2% |
Hepatic Function Abnormal |
4.2% |
Loss Of Consciousness |
4.2% |
Pyrexia |
4.2% |
Somnolence |
4.2% |
Stevens-johnson Syndrome |
4.2% |
Syncope |
4.2% |
Tremor |
3.6% |
Urticaria |
3.6% |
Erythema |
3.0% |
Hot Flush |
3.0% |
Rash |
3.0% |
|
Concomitant |
Premedication |
18.9% |
Prophylaxis |
17.4% |
Product Used For Unknown Indication |
13.8% |
Drug Use For Unknown Indication |
9.8% |
Renal Cell Carcinoma |
4.5% |
Hypertension |
4.3% |
Colon Cancer |
4.2% |
Rheumatoid Arthritis |
3.5% |
Rectal Cancer |
3.1% |
Non-hodgkin's Lymphoma |
2.6% |
Lymphoma |
2.2% |
Constipation |
2.1% |
Insomnia |
1.9% |
Colorectal Cancer |
1.9% |
Antiemetic Supportive Care |
1.9% |
Hiv Infection |
1.8% |
Breast Cancer |
1.7% |
Pain |
1.7% |
Hepatitis C |
1.4% |
Cancer Pain |
1.3% |
|
Vomiting |
12.7% |
White Blood Cell Count Decreased |
11.9% |
Pyrexia |
9.2% |
Sepsis |
5.9% |
Pneumonia |
5.3% |
Infusion Related Reaction |
5.2% |
Rash |
5.0% |
Urticaria |
4.5% |
Death |
3.9% |
Nausea |
3.9% |
Platelet Count Decreased |
3.9% |
Interstitial Lung Disease |
3.8% |
Thrombocytopenia |
3.8% |
Bone Marrow Failure |
3.3% |
Diarrhoea |
3.1% |
Pruritus |
3.1% |
Malaise |
3.0% |
Pleural Effusion |
3.0% |
Stomatitis |
2.8% |
Toxic Skin Eruption |
2.8% |
|
Interacting |
Acute Promyelocytic Leukaemia |
85.7% |
Infection |
14.3% |
|
Drug Interaction |
66.7% |
Myositis |
33.3% |
|